SAN DIEGO--(BUSINESS WIRE)--Aug. 8, 2006--Santarus, Inc. (NASDAQ:SNTS - News), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today reported financial and operating results for the quarter ended June 30, 2006. Key financial results for the second quarter of 2006 included:
